Grant Avenue Capital
Grant Avenue Capital is a New York–based, healthcare-focused middle-market private equity firm founded in 2019 that invests in US healthcare companies with $5M–$25M EBITDA, targeting founders, entrepreneurs, and management teams across founder recapitalizations, buyouts, minority investments, and carve-outs.
- Company typePrivate
- Founded2019
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Grant Avenue Capital does
Grant Avenue Capital is a healthcare-focused middle-market private equity firm founded in 2019 and headquartered at 437 Madison Avenue, New York. The firm targets US healthcare companies with $5M–$25M of EBITDA across healthcare services, pharma services, medtech, and healthcare IT, and executes founder recapitalizations, majority buyouts, minority investments, and corporate carve-outs. As of latest disclosure, the firm has completed 50+ transactions and its portfolio companies collectively employ over 7,400 people across nine disclosed platforms spanning physical therapy (H2 Health, 270+ clinics), home health/hospice (Fortis), hospital shared services (Ovation Healthcare), clinical research (Helios Clinical Research), home medical equipment (Performance Home Medical), life-sciences consulting (CREO), emergency medical transportation (PatientCare EMS), vitamins/supplements manufacturing (21st Century Healthcare), and EMS education (School of EMS).
The firm operates two differentiating programs: Grant Advantage, an operational excellence framework built around proprietary "Equity Alpha Drivers" and a "Value Creation Playbook" delivered through dedicated internal staff (e.g., Director of Business Development, Director of Strategy & Operational Excellence), and Grant Accelerator, an operating-executive program launched in 2024 that formalizes a bench of industry veterans — former CEOs of Multisorb, Buffalo Filter, Cambrex CDMO, and Midwest Medical Transport — who serve as Executive Chairs, CEOs, and active board members across the portfolio. The investing team is ~11–50 people, anchored by Founder/Managing Partner Buddy Gumina (formerly Senior Equity Partner at Apax Partners) plus Partners, Principals, VPs, and Associates drawn from Tailwind Capital, LLR Partners, RoundTable Healthcare, Audax, Morgan Stanley Capital Partners, Permira, and other healthcare-specialist shops.
Revenue mechanics are standard for a private equity manager: management fees on committed/ invested capital from limited partners, supplemented by transaction and performance-based fees, plus carried interest on successful exits. Investor relations are managed through a secure Intralinks portal, and deal sourcing is driven primarily by the team's healthcare operating network, executive relationships, and proprietary outreach rather than mass channels. The firm does not disclose AUM, fund size, or detailed financial metrics publicly.
Grant Avenue Capital firmographics
Firmographics- Name
- Grant Avenue Capital
- Legal name
- Grant Avenue Capital LLC
- Website
- https://grantave.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Grant Avenue Capital is a New York–based, healthcare-focused middle-market private equity firm founded in 2019 that invests in US healthcare companies with $5M–$25M EBITDA, targeting founders, entrepreneurs, and management teams across founder recapitalizations, buyouts, minority investments, and carve-outs.
- Ownership category
- akta.pro rank
Grant Avenue Capital industry classification
Industry- Product category
- Healthcare Private Equity
- NAICS
- Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Private Equity Buyout Fund-of-Funds (FSANAGAD)
- akta.pro secondary industry
- Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC)
Keywords
Where Grant Avenue Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Grant Avenue Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Management Fees: Standard private equity management fees charged to fund investors for asset management services
- Carried Interest: Performance-based carried interest from successful portfolio company exits
- Investment Returns: Returns from equity investments in healthcare companies across various transaction structures including buyouts, recapitalizations, and carve-outs
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Grant Avenue Capital product offering
Product offeringCore offering
Grant Avenue Capital is a healthcare-focused middle-market private equity firm that invests in healthcare companies with $5M to $25M in EBITDA through founder recapitalizations, majority buyouts, minority investments, and corporate carve-outs. The firm delivers operational support to portfolio companies through two proprietary programs: Grant Advantage (operational excellence built on Equity Alpha Drivers and a Value Creation Playbook) and Grant Accelerator (an operating-executive program that places industry veterans as Executive Chair, CEO, or Active Board Member in portfolio companies).
Product overview
Grant Avenue Capital is a healthcare-focused private equity firm (not a technology product company). The firm offers investment and operational services through its core programs: Grant Advantage (operational excellence) and Grant Accelerator (operating executive program). The investment strategy targets healthcare sub-sectors including healthcare services, pharma services, medtech, and healthcare IT for companies with $5M-$25M in EBITDA. The portfolio consists of 9 current investments spanning physical therapy (H2 Health), home health and hospice (Fortis), hospital shared services (Ovation Healthcare), clinical research (Helios Clinical Research), home medical equipment (Performance Home Medical), healthcare consulting (CREO), EMS transportation (PatientCare EMS), vitamins/supplements manufacturing (21st Century Healthcare), and EMS education (School of EMS).
Differentiator
Problem solved
Functional benefit
Products and services
- Grant Advantage
- Grant Accelerator
- Healthcare Private Equity Investment
Quantifiable outcome
- 50+ total transactions completed since founding in 2019
- +2 more outcomes
Companies that use Grant Avenue Capital
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles2 records
Grant Avenue Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Grant Avenue Capital partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
Grant Avenue Capital competitors and assessment
Company assessmentDirect peers
- Avista Capital Partners: Healthcare-focused middle-market private equity firm with comparable deal sizes and sub-sector focus on healthcare services, pharma services, and healthcare products.
- Varsity Healthcare Partners: Lower-middle-market private equity firm exclusively focused on healthcare services, providers, and outsourced services with similar EBITDA target ranges and founder-friendly structures.
- New Mountain Capital: Healthcare-focused growth-oriented PE firm that overlaps with Grant Avenue across pharma services, healthcare IT, and provider services, though typically at the upper end of the middle market.
- RoundTable Healthcare Partners: Healthcare-focused middle-market PE firm with a Brian Berkin pedigree connection, investing across medical products, pharma services, and specialty healthcare distribution at comparable deal sizes.
- Linden Capital Partners: Healthcare-focused middle-market private equity firm targeting similar lower-middle-market healthcare services and pharma services companies, with comparable transaction structures and operating partner models.
- Welsh, Carson, Anderson & Stowe: One of the longest-tenured healthcare-focused PE firms, investing across healthcare services, pharma services, and healthcare IT at the middle-market and growth stages with strong sector operating expertise.
Broad incumbents
- Bain Capital Private Equity: Global PE firm with a large dedicated healthcare team that competes with Grant Avenue in healthcare services and pharma services while also deploying checks across a much broader range of healthcare sub-sectors and company sizes.
- TPG Capital: Large global PE firm with a dedicated healthcare strategy (TPG Capital Healthcare) competing for the same healthcare services and pharma services assets at scale.
Emerging players
- Audax Group: Middle-market PE firm with a healthcare team that competes for similar $5M-$25M EBITDA healthcare assets and uses comparable buy-and-build strategies, with a known principal (Alex Ferree) connection to Grant Avenue.
- Chicago Pacific Founders: Healthcare-focused PE firm founded by former TPG and other healthcare executives, investing across healthcare services and technology with comparable founder-friendly and flexible capital structures.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Grant Avenue Capital social profiles
Digital presenceGrant Avenue Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Grant Avenue Capital leadership team
Management profileNumber of profiles
Profiles12 records
Grant Avenue Capital subsidiaries and ownership
Company hierarchySubsidiaries9 records
Grant Avenue Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Grant Avenue Capital M&A and investment
M&A and investmentM&A4 records
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Grant Avenue Capital
What does Grant Avenue Capital do?
Grant Avenue Capital is a healthcare-focused middle-market private equity firm that invests in healthcare companies with $5M to $25M in EBITDA through founder recapitalizations, majority buyouts, minority investments, and corporate carve-outs. The firm delivers operational support to portfolio companies through two proprietary programs: Grant Advantage (operational excellence built on Equity Alpha Drivers and a Value Creation Playbook) and Grant Accelerator (an operating-executive program that places industry veterans as Executive Chair, CEO, or Active Board Member in portfolio companies).
Is Grant Avenue Capital a public or private company?
Grant Avenue Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Grant Avenue Capital founded?
Grant Avenue Capital was founded in 2019. It employs 11 to 50 people.
Where is Grant Avenue Capital based?
Grant Avenue Capital is headquartered in New York, United States, in the North America region.
How does Grant Avenue Capital make money?
Three revenue lines are on record. Management Fees are the primary driver. The others are carried Interest and investment Returns.
Who are Grant Avenue Capital's main competitors?
Direct peers on record are Avista Capital Partners, Varsity Healthcare Partners, New Mountain Capital, RoundTable Healthcare Partners, Linden Capital Partners and Welsh, Carson, Anderson & Stowe. Broad incumbents are Bain Capital Private Equity and TPG Capital. Emerging players are Audax Group and Chicago Pacific Founders.
Does Grant Avenue Capital have an API?
No public API is recorded for Grant Avenue Capital.
What industry is Grant Avenue Capital in?
Grant Avenue Capital's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANAGAD, Private Equity Buyout Fund-of-Funds, with a secondary code of FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked). Its NAICS code is 523940 and its SIC code is 6282.